News
ANGO
11.98
+0.34%
0.04
Weekly Report: what happened at ANGO last week (0113-0117)?
Weekly Report · 2d ago
AngioDynamics Highlights Strategic Growth at Healthcare Conference
TipRanks · 6d ago
AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares
Seeking Alpha · 6d ago
AngioDynamics Publishes APEX-AV Trial Results In JSCAI
NASDAQ · 01/14 14:29
AngioDynamics announces publication of APEX-AV trial results in JSCAI
TipRanks · 01/13 13:55
AngioDynamics Announces 35.5% Clot Reduction With AlphaVac F1885 System in Trial, Meeting Primary Endpoints In Pulmonary Embolism Treatment Published In The Journal Of The Society For Cardiovascular Angiography & Interventions Titled "Novel Mechanical Aspiration Thrombectomy In Patients With Acute Pulmonary Embolism: Results From The Prospective APEX-AV Trial"
Benzinga · 01/13 13:37
Weekly Report: what happened at ANGO last week (0106-0110)?
Weekly Report · 01/13 09:26
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
Barchart · 01/13 07:00
AngioDynamics price target raised to $16 from $13 at Oppenheimer
TipRanks · 01/10 14:45
AngioDynamics Price Target Raised to $15.00/Share From $14.00 by HC Wainwright & Co.
Dow Jones · 01/10 13:41
AngioDynamics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 01/10 13:41
AngioDynamics’ Strong Financial Performance and Strategic Advancements Justify Buy Rating and Increased Price Target
TipRanks · 01/10 11:27
AngioDynamics price target raised to $15 from $14 at H.C. Wainwright
TipRanks · 01/10 11:25
ANGIODYNAMICS, INC. <ANGO.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $15 FROM $14
Reuters · 01/10 11:19
AngioDynamics price target raised to $15 from $12 at Canaccord
TipRanks · 01/09 16:10
Institutional investors are AngioDynamics, Inc.'s (NASDAQ:ANGO) biggest bettors and were rewarded after last week's US$154m market cap gain
Simply Wall St · 01/09 10:46
ANGIODYNAMICS INC <ANGO.O>: CANACCORD GENUITY RAISES TARGET PRICE TO $15 FROM $12
Reuters · 01/09 08:48
US RESEARCH ROUNDUP-Accolade, Costco Wholesale, RH
Reuters · 01/09 06:52
AngioDynamics, Inc. Reports Growth in Med Tech Segment
TipRanks · 01/09 03:50
AngioDynamics: A Surgical Approach To Market Growth
Seeking Alpha · 01/08 22:15
More
Webull provides a variety of real-time ANGO stock news. You can receive the latest news about Angiodynamics through multiple platforms. This information may help you make smarter investment decisions.
About ANGO
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.